Corrigendum to "A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy" [Nanomedicine 14(5) (2018) 1643-1654]

Mookkandi Palsamy Kesavan; Niranjan G Kotla; Srinivasan Ayyanaar; Gujuluva Gangatharan Vinoth Kumar; Gurusamy Rajagopal; Gandhi Sivaraman; Thomas J Webster; Jegathalaprathaban Rajesh

doi:10.1016/j.nano.2020.102193

Corrigendum to "A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy" [Nanomedicine 14(5) (2018) 1643-1654]

Nanomedicine. 2021 Oct:37:102193. doi: 10.1016/j.nano.2020.102193. Epub 2020 Mar 25.

Authors

Mookkandi Palsamy Kesavan¹, Niranjan G Kotla², Srinivasan Ayyanaar¹, Gujuluva Gangatharan Vinoth Kumar¹, Gurusamy Rajagopal³, Gandhi Sivaraman⁴, Thomas J Webster⁵, Jegathalaprathaban Rajesh⁶

Affiliations

¹ Chemistry Research Centre, Mohamed Sathak Engineering College, Kilakarai, Ramanathapuram (D.T.), Tamilnadu, India.
² Centre for Research in Medical Devices (CÚRAM), National University of Ireland Galway, Ireland.
³ PG and Research Department of Chemistry, Chikkanna Government Arts College, Tiruppur, Tamilnadu, India.
⁴ School of Chemistry, Madurai Kamaraj University, Madurai, India. Electronic address: raman474@gmail.com.
⁵ Department of Chemical Engineering, Northeastern University, Boston, MA, USA. Electronic address: th.webster@neu.edu.
⁶ Chemistry Research Centre, Mohamed Sathak Engineering College, Kilakarai, Ramanathapuram (D.T.), Tamilnadu, India. Electronic address: mkuraji@gmail.com.

PMID: 32222477
DOI: 10.1016/j.nano.2020.102193

No abstract available

Keywords: Anti-cancer drug delivery; Biosurfactant; Camptothecin and luotonin ACamptothecin and luotonin A; Iron oxide nanoparticles; Serum protein binding; Theranostic nanocagesTheranostic nanocages.

Publication types

Published Erratum